{"disease":{"id":"progress-free-survival-pfs-and-overall-survival-os","name":"progress free survival pfs and overall survival os"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04393220","title":"Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Fuda Cancer Hospital, Guangzhou","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}